Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
Kiarash Riazi, Hassan Azhari, Jacob H Charette, et al.
˜The œLancet. Gastroenterology & hepatology (2022) Vol. 7, Iss. 9, pp. 851-861
Closed Access | Times Cited: 1270

Showing 51-75 of 1270 citing articles:

Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes
Ying Shang, Emilie Toresson Grip, Angelo Modica, et al.
Diabetes Care (2024) Vol. 47, Iss. 6, pp. 978-985
Open Access | Times Cited: 19
Liver Cancer in 2021: Global Burden of Disease Study
En Ying Tan, Pojsakorn Danpanichkul, Jie Ning Yong, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 19
Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma
Suki Ha, Vincent Wai‐Sun Wong, Xiang Zhang, et al.
Gut (2024) Vol. 74, Iss. 1, pp. 141-152
Closed Access | Times Cited: 18
Integrated network pharmacology, metabolomics, and transcriptomics of Huanglian-Hongqu herb pair in non-alcoholic fatty liver disease
Xiaobo Zhang, Jie Zhang, Zubing Zhou, et al.
Journal of Ethnopharmacology (2024) Vol. 325, pp. 117828-117828
Closed Access | Times Cited: 17
Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease
Alessandro Cherubini, Sara Della Torre, Serena Pelusi, et al.
Trends in Molecular Medicine (2024)
Closed Access | Times Cited: 17
Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment
Norbert Stefan, Hannele Yki‐Järvinen, Brent A. Neuschwander‐Tetri
The Lancet Diabetes & Endocrinology (2024)
Open Access | Times Cited: 16
Dietary Niacin Intake and Mortality Among Individuals With Nonalcoholic Fatty Liver Disease
Jie Pan, Yujia Zhou, Nengzhi Pang, et al.
JAMA Network Open (2024) Vol. 7, Iss. 2, pp. e2354277-e2354277
Open Access | Times Cited: 15
Effects of empagliflozin on liver fat in patients with metabolic dysfunction–associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trial
Ka Shing Cheung, Ho Yu Ng, Rex Wan Hin Hui, et al.
Hepatology (2024) Vol. 80, Iss. 4, pp. 916-927
Closed Access | Times Cited: 15
Estimated Burden of Metabolic Dysfunction–Associated Steatotic Liver Disease in US Adults, 2020 to 2050
Phuc Le, Moosa Tatar, Srinivasan Dasarathy, et al.
JAMA Network Open (2025) Vol. 8, Iss. 1, pp. e2454707-e2454707
Open Access | Times Cited: 3
Modeling the Health and Economic Impact of Pharmacologic Therapies for MASLD in the United States
C. K. Wallace, Ivane Gamkrelidze, Chris Estes, et al.
Journal of Hepatology (2025)
Open Access | Times Cited: 2
"Evolving epidemiology of HCC in Spain"
Margarita Sala, Sonia Pascual, Montserrat Roca, et al.
JHEP Reports (2025), pp. 101336-101336
Open Access | Times Cited: 2
Association between NAFLD and liver fibrosis with nutritional risk index based on the NHANES 2017–2018
Jie-Ming Jian, Rui Zhang, Yuan Dong, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Letter: Global Burden of Metabolic Dysfunction‐Associated Steatotic Liver Disease‐Related Liver Cancer—Results From the Global Burden of Disease Study 2021
Chunlong Liu, Ziqiang He, Jiangtao Yu, et al.
Alimentary Pharmacology & Therapeutics (2025)
Open Access | Times Cited: 1
A BCL-xL/BCL-2 PROTAC effectively clears senescent cells in the liver and reduces MASH-driven hepatocellular carcinoma in mice
Yang Yang, Natacha Jn-Simon, Yonghan He, et al.
Nature Aging (2025)
Closed Access | Times Cited: 1
Fecal microbiota transplantation improves hepatic steatosis induced by HFD in a mouse model associated with liver ILC1 regulation and indole-3-carbinol level
Pengfei Hou, Yu Yao, Ying Wu, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access | Times Cited: 1
Emerging role of aging in the progression of NAFLD to HCC
Yongyuan He, Yinghong Su, Chengcheng Duan, et al.
Ageing Research Reviews (2022) Vol. 84, pp. 101833-101833
Closed Access | Times Cited: 45
CD47-SIRPα axis blockade in NASH promotes necroptotic hepatocyte clearance by liver macrophages and decreases hepatic fibrosis
Hongxue Shi, Xiaobo Wang, Fang Li, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 672
Open Access | Times Cited: 44
Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review
Kiarash Riazi, Mark G. Swain, Stephen E. Congly, et al.
Nutrients (2022) Vol. 14, Iss. 21, pp. 4556-4556
Open Access | Times Cited: 42
The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome
Dong Liu, Xue Gao, Xiong‐Fei Pan, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 38
DT-109 ameliorates nonalcoholic steatohepatitis in nonhuman primates
Pengxiang Qu, Oren Rom, Ke Li, et al.
Cell Metabolism (2023) Vol. 35, Iss. 5, pp. 742-757.e10
Open Access | Times Cited: 37
Major roles of kupffer cells and macrophages in NAFLD development
Soo-Jeung Park, Josefina Garcia Diaz, Eugene Um, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 35
Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study
Fahim Ebrahimi, Hannes Hagström, Jiangwei Sun, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 6, pp. 1374-1384
Open Access | Times Cited: 35
Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease
Anders Mellemkjær, Mikkel Breinholt Kjær, David Haldrup, et al.
European Journal of Internal Medicine (2023) Vol. 122, pp. 28-34
Open Access | Times Cited: 34
Global and national prevalence of nonalcoholic fatty liver disease in adolescents: An analysis of the global burden of disease study 2019
Phillipp Hartmann, Xinlian Zhang, Rohit Loomba, et al.
Hepatology (2023) Vol. 78, Iss. 4, pp. 1168-1181
Open Access | Times Cited: 33
Liver Fat Quantification With Ultrasound: Depth Dependence of Attenuation Coefficient
Giovanna Ferraioli, Ambra Raimondi, Laura Maiocchi, et al.
Journal of Ultrasound in Medicine (2023) Vol. 42, Iss. 10, pp. 2247-2255
Open Access | Times Cited: 33

Scroll to top